Sources | Names Used |
---|---|
CTRPv2 | SNX-2112:bortezomib (250:1 mol/mol) |
PharmacoGx | SNX-2112:bortezomib (250:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NASP | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |
mRNA | RFC3 | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |
mRNA | PRPF40A | CTRPv2 | pan-cancer | AAC | 0.13 | 4e-05 |
mRNA | EXOSC3 | CTRPv2 | pan-cancer | AAC | 0.13 | 4e-05 |
mRNA | GAS6 | CTRPv2 | pan-cancer | AAC | -0.13 | 4e-05 |
mRNA | ILF3 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
mRNA | LTBP2 | CTRPv2 | pan-cancer | AAC | -0.13 | 5e-05 |
mRNA | YIPF5 | CTRPv2 | pan-cancer | AAC | -0.15 | 5e-05 |
mRNA | TBC1D2 | CTRPv2 | pan-cancer | AAC | -0.16 | 5e-05 |
mRNA | IQCB1 | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-05 |